ArticleJournal of kidney cancer and VHL2026

Reduced-Dose Pazopanib as First-Line Therapy in Metastatic Renal Cell Carcinoma: Real-World Outcomes and Subsequent Treatment Patterns from a Resource-Constrained Setting in South India.

Arun Krishnan M P et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.